Patients with unstable angina pectoris show an increased frequency of the Fc gamma RIIa R131 allele

References

• Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008; 358:929–939.
   PubMed Web of Science ®Google Scholar
• Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med. 1994; 179:1317–1330.
   PubMed Web of Science ®Google Scholar
• Kuhn A, Herrmann M, Kleber S, . Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis Rheum. 2006; 54:939–950.
   PubMed Web of Science ®Google Scholar
• Baumann I, Kolowos W, Voll RE, . Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum. 2002; 46:191–201.
   PubMed Web of Science ®Google Scholar
• Herrmann M, Voll RE, Zoller OM, . Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 1998; 41:1241–1250.
   PubMed Web of Science ®Google Scholar
• Petri M. Sex hormones and systemic lupus erythematosus. Lupus. 2008; 17:412–415.
   PubMed Web of Science ®Google Scholar
• Block SR, Winfield JB, Lockshin MD, . Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. Am J Med. 1975; 59:533–552.
   PubMed Web of Science ®Google Scholar
• Deapen D, Escalante A, Weinrib L, . A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum. 1992; 35:311–318.
   PubMed Web of Science ®Google Scholar
• Li X, Ptacek TS, Brown EE, . Fcgamma receptors: structure, function and role as genetic risk factors in SLE. Genes Immun. 2009; 10:380–389.
   PubMed Web of Science ®Google Scholar
• Grossmayer GE, Munoz LE, Weber CK, . IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of systemic lupus erythaematosus sera. Ann Rheum Dis. 2008; 67:1626–1632.
   PubMedGoogle Scholar
• Munoz LE, Janko C, Chaurio RA, . IgG opsonized nuclear remnants from dead cells cause systemic inflammation in SLE. Autoimmunity. 2010; 43:232–235.
   PubMed Web of Science ®Google Scholar
• Munoz LE, Janko C, Grossmayer GE, . Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. Arthritis Rheum. 2009; 60:1733–1742.
   PubMed Web of Science ®Google Scholar
• Hamburger MI, Lawley TJ, Kimberly RP, . A serial study of splenic reticuloendothelial system Fc receptor functional activity in systemic lupus erythematosus. Arthritis Rheum. 1982; 25:48–54.
   PubMedGoogle Scholar
• Salmon JE, Kimberly RP, Gibofsky A, . Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc receptor-ligand binding and internalization. J Immunol. 1984; 133:2525–2531.
   PubMedGoogle Scholar
• Wardemann H, Yurasov S, Schaefer A, . Predominant autoantibody production by early human B cell precursors. Science. 2003; 301:1374–1377.
   PubMed Web of Science ®Google Scholar
• Zuniga R, Markowitz GS, Arkachaisri T, . Identification of IgG subclasses and C-reactive protein in lupus nephritis: the relationship between the composition of immune deposits and FCgamma receptor type IIA alleles. Arthritis Rheum. 2003; 48:460–470.
   PubMedGoogle Scholar
• Gershov D, Kim S, Brot N, . C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J Exp Med. 2000; 192:1353–1364.
   PubMed Web of Science ®Google Scholar
• Vogt B, Fuhrnrohr B, Muller R, . CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis. Autoimmunity. 2007; 40:295–298.
   PubMed Web of Science ®Google Scholar
• Manfredi AA, Rovere-Querini P, Bottazzi B, . Pentraxins, humoral innate immunity and tissue injury. Curr Opin Immunol. 2008; 20:538–544.
   PubMed Web of Science ®Google Scholar
• Rhodes B, Furnrohr BG, Vyse TJ. C-reactive protein in rheumatology: biology and genetics. Nat Rev Rheumatol. 2011; 7:282–289.
   PubMed Web of Science ®Google Scholar
• Ohl K, Tenbrock K. Inflammatory cytokines in systemic lupus erythematosus. J Biomed Biotechnol. 2011; 2011 doi:10.1155/2011/432595.
   PubMedGoogle Scholar
• Karassa FB, Bijl M, Davies KA, . Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis. Arthritis Rheum. 2003; 48:1930–1938.
   PubMed Web of Science ®Google Scholar
• van Sorge NM, van der Pol WL, van de Winkel JG. FcgammaR polymorphisms: Implications for function, disease susceptibility and immunotherapy. Tissue Antigens. 2003; 61:189–202.
   PubMed Web of Science ®Google Scholar
• Hernandez-Vargas P, Ortiz-Munoz G, Lopez-Franco O, . Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice. Circ Res. 2006; 99:1188–1196.
   PubMedGoogle Scholar
• Yuan H, Pan HF, Li LH, . Meta analysis on the association between FcgammaRIIa-R/H131 polymorphisms and systemic lupus erythematosus. Mol Biol Rep. 2009; 36:1053–1058.
   PubMedGoogle Scholar
• Manger K, Repp R, Jansen M, . Fcgamma receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms. Ann Rheum Dis. 2002; 61:786–792.
   PubMed Web of Science ®Google Scholar
• Manger K, Manger B, Repp R, . Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis. 2002; 61:1065–1070.
   PubMed Web of Science ®Google Scholar
• Haque S, Gordon C, Isenberg D, . Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the lupus and atherosclerosis evaluation of risk (LASER) study. J Rheumatol. 2010; 37:322–329.
   PubMed Web of Science ®Google Scholar
• Savonitto S, Ardissino D, Granger CB, . Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA. 1999; 281:707–713.
   PubMed Web of Science ®Google Scholar
• Raaz D, Herrmann M, Ekici AB, . FcgammaRIIa genotype is associated with acute coronary syndromes as first manifestation of coronary artery disease. Atherosclerosis. 2009; 205:512–516.
   PubMedGoogle Scholar
• Hamm CW, Braunwald E. A classification of unstable angina revisited. Circulation. 2000; 102:118–122.
   PubMed Web of Science ®Google Scholar
• Abrams J. Clinical practice. Chronic stable angina. N Engl J Med. 2005; 352:2524–2533.
   PubMed Web of Science ®Google Scholar
• Rascu A, Repp R, Westerdaal NA, . Clinical relevance of Fc gamma receptor polymorphisms. Ann NY Acad Sci. 1997; 815:282–295.
   PubMed Web of Science ®Google Scholar
• Carlsson LE, Santoso S, Baurichter G, . Heparin-induced thrombocytopenia: new insights into the impact of the FcgammaRIIa-R-H131 polymorphism. Blood. 1998; 92:1526–1531.
   PubMed Web of Science ®Google Scholar
• Bharadwaj D, Stein MP, Volzer M, . The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. J Exp Med. 1999; 190:585–590.
   PubMed Web of Science ®Google Scholar
• Danesh J, Wheeler JG, Hirschfield GM, . C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004; 350:1387–1397.
   PubMed Web of Science ®Google Scholar
• Kroupis C, Theodorou M, Chaidaroglou A, . The association between a common FCGR2A polymorphism and C-reactive protein and coronary artery disease revisited. Genet Test Mol Biomarkers. 2010; 14:839–846.
   PubMed Web of Science ®Google Scholar
• Joutsi L, Javela K, Partanen J, . Genetic polymorphism H131R of Fcgamma receptor type IIA (FcgammaRIIA) in a healthy Finnish population and in patients with or without platelet-associated IgG. Eur J Haematol. 1998; 61:183–189.
   PubMedGoogle Scholar
• Dijstelbloem HM, Hepkema BG, Kallenberg CG, . The R-H polymorphism of FCgamma receptor IIa as a risk factor for systemic lupus erythematosus is independent of single-nucleotide polymorphisms in the interleukin-10 gene promoter. Arthritis Rheum. 2002; 46:1125–1126.
   PubMedGoogle Scholar
• Atsumi T, Caliz R, Amengual O, . Fcgamma receptor IIA H/R131 polymorphism in patients with antiphospholipid antibodies. Thromb Haemost. 1998; 79:924–927.
   PubMedGoogle Scholar
• Murphy A, White A, Nair R, . C-reactive protein and Fc gamma RIIa functional polymorphisms are not associated with clinical presentation of stable and unstable angina. Thromb Haemost. 2007; 97:681–682.
   PubMedGoogle Scholar
• Gardemann A, Horstmann A, Santoso S. Fc gamma RIIa-R131H polymorphism: its impact on coronary heart disease in a German cohort. Thromb Haemost. 2003; 90:1218–1220.
   PubMedGoogle Scholar
• Gavasso S, Nygard O, Pedersen ER, . Fcgamma receptor IIIA polymorphism as a risk-factor for coronary artery disease. Atherosclerosis. 2005; 180:277–282.
   PubMedGoogle Scholar
• Karakas M, Hoffmann MM, Vollmert C, . Genetic variation in Fc gamma receptor IIa and risk of coronary heart disease: negative results from two large independent populations. BMC Med Genet. 2009; 10:46.
   PubMedGoogle Scholar
• Buffon A, Biasucci LM, Liuzzo G, . Widespread coronary inflammation in unstable angina. N Engl J Med. 2002; 347:5–12.
   PubMed Web of Science ®Google Scholar
• Liuzzo G, Santamaria M, Biasucci LM, . Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation. J Am Coll Cardiol. 2007; 49:185–194.
   PubMed Web of Science ®Google Scholar
• Pepys MB, Hirschfield GM, Tennent GA, . Targeting C-reactive protein for the treatment of cardiovascular disease. Nature. 2006; 440:1217–1221.
   PubMed Web of Science ®Google Scholar
• Hillyard DZ, Cameron AJ, McDonald KJ, . Simvastatin inhibits lymphocyte function in normal subjects and patients with cardiovascular disease. Atherosclerosis. 2004; 175:305–313.
   PubMed Web of Science ®Google Scholar
• Sjowall C, Bengtsson AA, Sturfelt G, . Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus. Arthritis Res Ther. 2004; 6:R87–R94.
   PubMed Web of Science ®Google Scholar